Primary study · included by 1 review

Abdelhafez 2022

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry.

Non-Cochrane · intervention · 2026 · cited as Abdelhafez 2022 · Table 2; Reference 41

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · <360 days	RR 0.99 [0.96, 1.02]	7 studies · 400 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days	RR 0.95 [0.89, 1.01]	5 studies · 355 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) for pulpotomy vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days	RR 0.95 [0.85, 1.06]	2 studies · 124 participants	Low

1 including review in total.